Noom
Fully-mobile programs prevent/manage/reverse chronic and pre-chronic conditions such as obesity, diabetes and hypertension.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
N/A | Late VC | ||
| Total Funding | 000k | ||
| USD | 2019 | 2020 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 69 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Noom is a behavior change company that disrupts the weight loss and healthcare industries by integrating artificial intelligence, mobile technology, and psychological principles with empathetic personal coaching. Serving over 50 million users, Noom offers behavior change courses and a virtual diabetes prevention program recognized by the CDC. The platform is utilized by leading healthcare and pharmaceutical companies to enhance patient treatment outcomes globally. Headquartered in New York City, Noom employs a distributed workforce worldwide.
Keywords: behavior change, weight loss, healthcare, AI, mobile technology, psychology, personal coaching, diabetes prevention, treatment outcomes, global.